Amgen Inc
NASDAQ:AMGN
Amgen Inc
NASDAQ:AMGN
Price:
300.19 USD
-1.85%
Market Closed
Updated:
May 29, 2024
Amgen Inc
Net Income
|
Amgen Inc
Net Income Peer Comparison
Comparables:
ABBV
GILD
MRNA
VRTX
REGN
Competitive Net Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Income
$3.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-2%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Income
$6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
4%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Income
-$959m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Moderna Inc
NASDAQ:MRNA
|
Net Income
-$6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-68%
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Income
$4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Income
$3.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
26%
|
See Also
What is Amgen Inc's Net Income?
Net Income
3.8B
USD
3.8B
USD
Based on the financial report for Mar 31, 2024, Amgen Inc's Net Income amounts to 3.8B USD.
What is Amgen Inc's Net Income growth rate?
Net Income CAGR 10Y
-2%
-2%
Over the last year, the Net Income growth was -52%. The average annual Net Income growth rates for Amgen Inc have been -19% over the past three years , -14% over the past five years , and -2% over the past ten years .
You don't have any saved screeners yet
